GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prescient Therapeutics Ltd (GREY:PSTTF) » Definitions » Net Investment Income

Prescient Therapeutics (Prescient Therapeutics) Net Investment Income


View and export this data going back to 2017. Start your Free Trial

What is Prescient Therapeutics Net Investment Income?

Net Investment Income only applies to insurance companies.


Prescient Therapeutics (Prescient Therapeutics) Business Description

Traded in Other Exchanges
Address
Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205
Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.